Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

229.39
+0.75610.33%
Post-market: 230.310.9178+0.40%19:30 EDT
Volume:3K
Turnover:654.13K
Market Cap:464.86M
PE:- -
High:230.31
Open:229.91
Low:229.39
Close:228.64
52wk High:244.35
52wk Low:160.91
Shares:2.03M
Float Shares:2.03M
Volume Ratio:0.25
T/O Rate:0.14%
Dividend:0.96
Dividend Rate:0.42%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05

Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement

Reuters
·
Sep 05

Amgen is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Sep 05

Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000

Reuters
·
Sep 04

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 04

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

TIPRANKS
·
Sep 04

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

TIPRANKS
·
Sep 04

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

TIPRANKS
·
Sep 03

Political and General News Events from September 3

Reuters
·
Sep 03

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Reuters
·
Sep 03

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 03

Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target

TIPRANKS
·
Sep 03

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

TIPRANKS
·
Sep 03

NEJM publishes Phase 1/2 clinical data on daraxonrasib

TIPRANKS
·
Sep 03

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 03

Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million

Reuters
·
Sep 03

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Reuters
·
Sep 03

Amgen to Present at Wells Fargo Healthcare Conference Webcast

Reuters
·
Sep 03

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
Sep 03

Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit

Reuters
·
Sep 03